T1	Participants 1119 1380	The target patient population comprises OPSCC patients who would be unlikely to require chemotherapy post-resection: Tumor stage T1-T2 with likely negative margins at surgery; Nodal stage N0-2, â‰¤3 cm in size, with no evidence of extranodal extension on imaging.
T2	Participants 2022 2045	A sample of 68 patients
